fashion -WSS

fashion

author：knowledge 2025-09-29 19:57:38 - browse：73187

The Chamber of Commerce in downtown Washington, DC. — The U.S. Chamber of Commerce sued to stop a new Medicare drug price negotiation program from going into effect. Adobe

WASHINGTON — Attorneys for the U.S. Chamber of Commerce and the federal government sparred Friday over whether drugmakers have enough say in Medicare’s new drug price negotiation program, in the first oral arguments in a lawsuit challenging the new law.

The two sides debated two questions: whether the Chamber of Commerce would be sufficiently injured by the law to file a lawsuit, and whether the negotiation program was a violation of drugmakers’ due process rights.

The hearing was held in the U.S. District Court for the Southern District of Ohio, and Judge Michael Newman, a Trump nominee, presided. Newman didn’t ask any questions of the attorneys, so the hearing didn’t provide any hints about which way he might be leaning on the issues.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Johnson & Johnson sues to stop Medicare negotiation

WSS

Tuberculosis patients need more than just free medication

15 die by electrocution after transformer explodes in northern India

Twill hunts for pharma partner to market its depression app

FDA seeking to stop procedures at two unregulated stem cell clinics

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

Tuberculosis patients need more than just free medication

hotspot

fashion

knowledge

The cancer drug shortage isn’t new — and neither are the solutions

FDA seeking to stop procedures at two unregulated stem cell clinics

Affirmative action in medical school literally saved lives

BridgeBio heart drug succeeds in pivotal study

Medicare details structure of new drug price negotiation program

Robert Kennedy Jr.'s presidential campaign attracts GOP

FDA approval of Sarepta Duchenne genetic therapy gives me hope

It was time to plan for my old age. If only I could stop crying

BioMarin wins approval for gene therapy to treat hemophilia A

Johnson & Johnson sues to stop Medicare negotiation

focus

Lack of darker skin in textbooks, journals harms patients of color

More hospitals are billing patients as online messages surge

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

Lack of darker skin in textbooks, journals harms patients of color

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

Wikipedia

knowledge

hotspot

explore